Asclepius Medical Center OOD

At Asclepius Medical Center OOD in Dupnitsa, a major share of research focuses on atopic dermatitis, chronic spontaneous urticaria, vitiligo, and plaque psoriasis. These studies are designed to test new treatment options, assess symptom control, and understand long-term safety in people living with persistent inflammatory skin conditions.

• Evaluating new therapies for atopic dermatitis and related eczema conditions
• Studying treatment effectiveness in chronic spontaneous urticaria and other hives disorders
• Assessing options for vitiligo and plaque psoriasis to improve skin symptoms and quality of life

These trials reflect a strong focus on immune system diseases and practical care questions, especially how well modern therapies work over time.

The site also supports research in asthma and chronic obstructive pulmonary disease, two important respiratory tract diseases. The trials are aimed at improving breathing outcomes, reducing flare-ups, and finding better ways to manage long-term lung disease in adults and adolescents.

• Testing treatments for severe and inadequately controlled asthma
• Studying approaches for COPD to lower exacerbations and support lung function
• Exploring ways to improve daily respiratory control and long-term disease management

This area of research is especially relevant for patients with ongoing symptoms who need better prevention of worsening disease.

Clinical trials at this hospital/clinic also cover cardiovascular diseases and nutritional and metabolic diseases, including atherosclerotic cardiovascular disease, hyperlipidemia, and overweight or obesity. The main purpose is to evaluate new ways to reduce risk factors, support weight management, and prevent serious heart-related events.

• Investigating treatments for high cholesterol and vascular risk
• Studying weight-reduction strategies in overweight and obesity
• Assessing prevention-focused approaches for cardiovascular disease

These studies combine prevention and treatment goals, with an emphasis on improving long-term health outcomes.

Research at Asclepius Medical Center OOD includes work on virus diseases such as COVID-19 and seasonal influenza. The trials are centered on testing antiviral treatment options and evaluating vaccine responses, helping to strengthen protection against common and potentially serious infections.

• Evaluating therapies for COVID-19 in people at higher risk of severe illness
• Studying influenza immunisation and immune response in older adults
• Supporting research on infection control and prevention

This work connects treatment development with public health prevention, especially for vulnerable patient groups.

The site’s portfolio also includes trials in mental disorders, particularly schizophrenia, alongside broader studies of immune system phenomena. These projects aim to improve symptom control, assess tolerability of new options, and better understand immune-related disease activity across different conditions.

• Testing new approaches for schizophrenia and persistent psychiatric symptoms
• Exploring immune-related disease processes across inflammatory conditions
• Supporting research that may improve everyday functioning and treatment response

Overall, this research area adds important breadth to the site’s clinical trial activity, linking behavioral health with immune-focused investigation.